The PGC-1α level, a well-known AMPK downstream target [36], was also elevated in GRP-supplemented mice, indicating that GRP protected against colitis partially through stimulating the AMPK/PGC-1α pathway. This evidence concerns the gene PPARGC1A and colitis.